Adenovirus-mediated thymidine kinase gene therapy in combination with topotecan for patients with recurrent ovarian cancer: 2.5-year follow-up. - Hasenburg,A.; Tong,X.W.; Fischer,D.C.; Rojas-Martinez,A.; Nyberg-Hoffman,C.; Kaplan,A.L.; Kaufman,R.H.; Ramzy,I.; Aguilar-Cordova,E.; Kieback,D.G. (Gynecol Oncol, 2001)